Researchers have uncovered a mechanism that allows breast cancer to send metastases to the brain, potentially enabling the ...

MGM Cancer Institute successfully treats a 41-year-old man with advanced tongue cancer through chemotherapy, surgery, and ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Brenus Pharma, a clinical stage biotechnology company unlocking the immune system in vivo to fight solid tumors, announced ...

CT scan of chest, abdomen, and pelvis shows high-disease burden, including multiple mediastinal and hilar nodes, deposits in ...

Ceralasertib is an oral selective inhibitor of the ATR kinase, an important DNA-repairing protein in tumor cells.

SIL204 Demonstrated Significant Tumor Inhibition in Positive Pre Clinical Studies with Activity Across Pancreatic, Colorectal ...

An international team of researchers led by Hokkaido University has characterized the unique mechanics that enable Arcella, a ...

Aktis Oncology, Inc. targets $200M IPO to advance radiopharmaceuticals for solid tumors. Click for more on the upcoming AKTS ...

Delayed musculoskeletal symptoms after breast radiotherapy can reflect osteoradionecrosis rather than recurrence, thus ...

Bacteria in head and neck tumor stimulate immunotherapy resistance by attracting immune cells and creating a shield.

Abu Dhabi University (ADU) has announced the inauguration of the Abu Dhabi University Cancer Research Institute (ADU-CRI), a ...